UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K |
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 3, 2012
Cardinal Health, Inc.
(Exact name of registrant as specified in its charter)
Ohio | 1-11373 | 31-0958666 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
7000 Cardinal Place, Dublin, Ohio 43017
(Address of principal executive offices) (Zip Code)
(614) 757-5000
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 7.01 Regulation FD Disclosure
On February 3, 2012 Cardinal Health, Inc. (the Company) issued a press release concerning the Drug Enforcement Administrations actions at the Companys Lakeland, Fla., distribution center. A copy of the press release is included as Exhibit 99.1 to this report.
The Company has scheduled a conference call to be held at 12:00 p.m. Eastern on February 3, 2012 to discuss the Drug Enforcement Administrations actions.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
99.1 | Press Release issued by the Company on February 3, 2012 |
- 2 -
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Cardinal Health, Inc. | ||||
(Registrant) | ||||
Date: February 3, 2012 | By: | /s/ Craig S. Morford | ||
Name: Craig S. Morford | ||||
Title: Chief Legal and Compliance Officer |
- 3 -
EXHIBIT INDEX
99.1 | Press Release issued by the Company on February 3, 2012 |
- 4 -